Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

38.62
Delayed Data
As of May 23
 -0.54 / -1.38%
Today’s Change
21.11
Today|||52-Week Range
39.96
+25.31%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close39.16
Today’s open39.39
Day’s range38.50 - 39.46
Volume301,351
Average volume (3 months)239,508
Market cap$1.3B
Dividend yield--
Data as of 05/23/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+26.82%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+25.14%
P/E ratio101.6
Price/Sales10.05
Price/Book7.85

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...-1.05-3.50%
CORTCorcept Therapeutics...-0.03-0.25%
INVAInnoviva Inc+0.01+0.08%
ARRYArray Biopharma Inc-0.07-0.83%
Data as of 05/23/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.15
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts